Total Funding
44
77
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
62571
Sarcio uses regenerative cartilage cell therapy to treat patients suffering from the effects of Osteoarthritis.
- Amanda Vegoe: Co-Founder and COO
- Timothy O’Brien: Co-Founder and CSO
About the Company
Sarcio uses regenerative cartilage cell therapy to treat patients suffering from the effects of Osteoarthritis. Sarcio restores hyaline cartilage and reduces inflammation using an evidence-based induced pluripotent stem cell (iPSC) derived hyaline cartilage cell therapy. The company is also developing an off-the-shelf, injectable, regenerative
therapy to delay or prevent the need for joint replacement.
Women Founded
